These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36990277)

  • 41. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Markers and Targets in Melanoma.
    Teixido C; Castillo P; Martinez-Vila C; Arance A; Alos L
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.
    Lodde GC; Jansen P; Möller I; Sucker A; Hassel JC; Forschner A; Eckardt J; Meier F; Reinhardt L; Kähler KC; Ziemer M; Schlaak M; Rahimi F; Schatton K; Meiss F; Gutzmer R; Pföhler C; Terheyden P; Schilling B; Sachse M; Heppt MV; Sindrilaru A; Leiter U; Zaremba A; Thielmann CM; Ugurel S; Zimmer L; Hadaschik E; Bechrakis NE; Schadendorf D; Westekemper H; Livingstone E; Griewank KG;
    Eur J Cancer; 2022 May; 166():60-72. PubMed ID: 35279471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
    Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
    J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical expression of melanocytic and myofibroblastic markers and their molecular correlation in atypical fibroxanthomas and pleomorphic dermal sarcomas.
    Helbig D; Mauch C; Buettner R; Quaas A
    J Cutan Pathol; 2018 Dec; 45(12):880-885. PubMed ID: 30155964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event.
    Rüping K; Altendorf-Hofmann A; Chen Y; Kampmann E; Gibis S; Lindner L; Katenkamp D; Petersen I; Knösel T
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1315-22. PubMed ID: 24804818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
    Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
    ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation Sequencing.
    Zheng B; Qu Y; Wang J; Shi Y; Yan W
    Cancer Genomics Proteomics; 2019; 16(3):221-228. PubMed ID: 31018952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
    Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.
    Chen S; Fritchie K; Wei S; Ali N; Curless K; Shen T; Brini AT; Latif F; Sumathi V; Siegal GP; Cheng L
    Hum Pathol; 2017 Jul; 65():239-246. PubMed ID: 28552826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
    Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
    J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden.
    Raj SKS; Routh ED; Chou JW; Votanopoulos KI; Triozzi PL; Miller LD
    Cancer; 2022 Sep; 128(17):3254-3264. PubMed ID: 35767280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of a melanoma in situ to a sarcomatoid dedifferentiated melanoma.
    Chung J; Shevchenko A; Lee JB
    J Cutan Pathol; 2021 Jul; 48(7):943-947. PubMed ID: 33675557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predominance of triple wild-type and IGF2R mutations in mucosal melanomas.
    Iida Y; Salomon MP; Hata K; Tran K; Ohe S; Griffiths CF; Hsu SC; Nelson N; Hoon DSB
    BMC Cancer; 2018 Oct; 18(1):1054. PubMed ID: 30373548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas.
    Kreiger PA; Judkins AR; Russo PA; Biegel JA; Lestini BJ; Assanasen C; Pawel BR
    Mod Pathol; 2009 Jan; 22(1):142-50. PubMed ID: 18997735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma.
    Jiang J; Ding Y; Wu M; Chen Y; Lyu X; Lu J; Wang H; Teng L
    Cancer Med; 2020 Nov; 9(22):8498-8518. PubMed ID: 32969604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Case Report: Two Cases of Soft-Tissue Sarcomas: High TMB as a Potential Predictive Biomarker for Anlotinib Combined With Toripalimab Therapy.
    Li Y; Liu Y; Qu Y; Chen X; Qu X; Ye Y; Du X; Cheng Y; Xu M; Zhang H
    Front Immunol; 2022; 13():832593. PubMed ID: 35603147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genomic Insights Into High-Grade Infarct-Associated Bone Sarcomas.
    Tvrdik T; Gjeorgjievski SG; Wong P; Oskouei S; Read W; Bahrami A
    Mod Pathol; 2024 Oct; 37(10):100572. PubMed ID: 39033963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations.
    Haugh AM; Osorio RC; Francois RA; Tawil ME; Tsai KK; Tetzlaff M; Daud A; Vasudevan HN
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case report: The activity of multi-kinase VEGF inhibitor, Pazopanib, in metastatic undifferentiated round cell sarcomas harboring
    Campoverde L; Camacho F; Alessandrino F; Evans MG; Elliot A; Rosenberg A; Trent J
    Front Oncol; 2023; 13():1215003. PubMed ID: 37829338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.